Close Menu

NEW YORK – Biocept said today that it received a notice from Nasdaq last week that it has failed to comply with a minimum bid price rule, which requires that companies listed on the Nasdaq Capital Market maintain a minimum closing bid price of at least $1.00 per share. As a result, it could face delisting action.

The firm has a 180 calendar-day grace period to regain compliance, by maintaining a minimum closing bid price for its stock of at least $1.00 per share for a minimum of 10 consecutive business days during the 180-calendar-day grace period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers have developed a robotic lab assistant, the Verge reports.

CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.

The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.

In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.